Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
AstraZeneca completes balcinrenone/dapagliflozin PK study; posts two new observational trialsOct 23Weekly roundup, 12 itemsabemaciclibAstraZeneca
Lilly posts Phase 3 results for orforglipron and lebrikizumab; discloses abemaciclib trial haltOct 16Weekly roundup, 7 itemsabemaciclibBayerUpdated
Madrigal registers two resmetirom studies: Phase 1b in MASH/HFpEF and Phase 4 drug-interaction trialOct 16Weekly roundup, 2 itemsMadrigal Pharmaceuticals, Inc.resmetirom
Madrigal registers Phase 4 safety study of Rezdiffra with diabetes drugs in MASH patientsSep 29Trial updateMadrigal Pharmaceuticals, Inc.resmetirom
Olaparib Phase 2 results posted; three diabetes labels updated; new myeloma CAR-T trial recruitsAug 14Weekly roundup, 9 itemsAstraZenecaAZD0120